Mixed acute kidney allograft rejection after an antiprogrammed cell death protein 1 antibody treatment for lung epidermoid carcinoma

Transpl Int. 2016 Nov;29(11):1247-1248. doi: 10.1111/tri.12834. Epub 2016 Sep 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Allografts
  • Antibodies / therapeutic use*
  • CTLA-4 Antigen / metabolism
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / therapy*
  • Cell Death
  • Graft Rejection / immunology*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation
  • Lung Neoplasms / immunology
  • Lung Neoplasms / therapy*
  • Male
  • Middle Aged
  • Programmed Cell Death 1 Receptor / immunology*
  • Risk

Substances

  • Antibodies
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunosuppressive Agents
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor